No CrossRef data available.
Article contents
Screening for Birth Defects: A Professional Liability Alert
Published online by Cambridge University Press: 28 April 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- President's Column
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 1985
References
United Kingdom Collaborative Study on Alpha-Fetoprotein in Relation to Neural-Tube Defects, Maternal Serum-Alpha-Fetoprotein Measurement in Antenatal Screening for Anencephaly and Spina Bifida in Early Pregnancy, Lancet 1(8026): 1323–32 (June 25, 1977); Milunsky, A., Prenatal Detection of Neural Tube Defects: VI, Experience with 20,000 Pregnancies, Journal of the American Medical Association 244(24): 2731–35 (December 19, 1980); Milunsky, A. Alpert, E., Results and Benefits of a Maternal Serum Alpha-Fetoprotein Screening Program, Journal of the American Medical Association 252(11): 1438–42 (September 21, 1984).Google Scholar
Cuckle, H.S., Wald, N.J., Lindenbaum, R.H., Maternal Serum Alpha-Fetoprotein Measurement: A Screening Test for Down Syndrome, Lancet 1(8383): 926–29 (April 28, 1984).Google ScholarPubMed